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Abstract
Background: The search for biologic endpoints and biomarkers in the study of breast cancer risk
assessment and risk reduction strategies has led to an interest in obtaining cytologic information
and other biomarkers from nipple aspirate fluid (NAF).
Methods: This descriptive study examined factors associated with an increased ability to obtain
NAF in a cohort of 3043 women between the ages of 15 and 89 years of age. The majority of
women were between the ages of 30–49 (N = 1529/50.2%). Variables examined in relation to
obtaining fluid include: age, marital status, age at menarche, menopausal status, a history of
pregnancy, a history of breast-feeding, estrogen use, oral contraceptive use, endocrine disorders
and tranquilizer use.
Results: On average, women from whom breast fluid was obtained were younger than women
from whom breast fluid was attempted but not obtained (mean = 41.9 years versus 46.5 years, p
< 0.0001). In unadjusted and age-adjusted comparisons, being married, a history of pregnancy,
younger age at menarche (12 years of age or younger), tranquilizer use, oral contraceptive pill
(OCP) use and endocrine problems were associated with an increased ability to obtain breast fluid.
Post-menopausal status and exogenous estrogen use were associated with a decreased ability to
obtain breast fluid. After age-adjustment, oral contraceptive use was no longer significantly
associated with an increased ability to obtain fluid and post-menopausal status was no longer
associated with a decreased ability to obtain breast fluid. After multivariate adjustment, age, being
married, a history of pregnancy, tranquilizer use and a history of endocrine problems remained
positively associated with the ability to obtain breast fluid. In addition, menopausal women who
took estrogen were less likely to yield fluid than premenopausal women.
Conclusion: Four variables (being married, history of pregnancy, tranquilizer use and endocrine
disorders) remained positively associated with the ability to obtain NAF in all analyses. A younger
age was consistently associated with a greater ability to obtain NAF in this and other studies.
Published: 17 October 2006
BMC Women's Health 2006, 6:15 doi:10.1186/1472-6874-6-15
Received: 19 May 2006
Accepted: 17 October 2006
This article is available from: http://www.biomedcentral.com/1472-6874/6/15
© 2006 Baltzell et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Women's Health 2006, 6:15 http://www.biomedcentral.com/1472-6874/6/15
Page 2 of 8
(page number not for citation purposes)
Background
The search for early stage breast cancer, or more impor-
tantly, its precursors, is the goal of many researchers hop-
ing to reduce mortality rates from this disease. Current
methods of breast cancer early detection include mam-
mography, ultrasound, clinical breast exam (CBE) and
breast self-examination (BSE). In addition to these meth-
ods, other imaging techniques such as magnetic reso-
nance imaging (MRI) are being explored [1]. Although
these cancer detection methods have been used success-
fully for specific populations, biomarkers that come
directly from the breast cells may add to the information
obtained from the above-mentioned detection methods.
One of the commonly used detection methods, mam-
mography, appears to be less sensitive for younger women
(<55 years) [2]. Despite high suspicion of malignancy in
mammography, CBE or BSE, a breast cancer diagnosis
cannot be made definitively without tissue or cytologic
confirmation. More importantly, concentrating on pre-
cursors of breast cancer would allow for intervention prior
to the development of a malignancy. Intermediate bio-
logic endpoints are also necessary for the evaluation of
chemopreventive therapies [3]. Recent studies have indi-
cated that cells from nipple aspirate fluid (NAF) may yield
useful information for enhancing breast cancer risk assess-
ment [4]. However, sensitivity has been found to be low
in recent studies using other methods of breast fluid anal-
ysis for detection of breast cancer, including peri-areolar
fine needle aspiration and ductal lavage [5,6]. Determin-
ing which populations will derive the most benefit from
the analysis of breast fluid requires additional study of the
characteristics of the women most likely to yield fluid
resulting in an accurate cytologic diagnosis. Analyzing
cells in NAF is a step toward identifying tissue and/or
serum based markers of breast cancer risk as 70% of
women who develop breast cancer have no identifiable
risks factors [7].
In order to utilize NAF as both an adjunct to current breast
cancer risk assessment tools and/or for breast cancer early
detection, it is important to understand factors influenc-
ing the obtainment of adequate fluid samples. Past stud-
ies have shown four factors consistently associated with
an increased ability to obtain breast fluid; age between
35–50 years, earlier age at menarche, non-Asian com-
pared to Asian ethnicity and a history of lactation [8].
Using a descriptive cross-sectional design, this study
examined demographic, menstrual, reproductive and
other factors in relation to the ability to obtain NAF in a
group of 3043 non-lactating women from the Santa Bar-
bara, California area.
Methods
Subjects
All women were volunteers seen in a private breast clinic
by one physician, Dr. Otto Sartorius, who attempted NAF
collection on 3413 women. The women came to the clinic
for a variety of reasons and NAF was attempted as part of
Dr. Sartorius's normal evaluation. The volunteers con-
sisted of women without known breast disease, as well as
private clinic patients with known or suspected breast dis-
ease [9]. For this paper, all women with breast cancer or
women who were diagnosed with breast cancer within six
months of their initial clinic visit were excluded from the
analysis, reducing the number of eligible subjects to 3043.
Dr. Sartorius was a pioneer in the field of breast cancer
research, conducting multiple studies in the area of NAF.
Upon his death in 1994, Dr. Susan Love was named med-
ical director of his research foundation. The records of Dr.
Sartorius are held by The Dr. Susan Love Research Foun-
dation, which granted access to the records to this study's
first author, Kimberly Baltzell. Data regarding the obtain-
ment of NAF and medical, reproductive and other factors
were abstracted from medical records by a team led by
Sandra Tillisch, R.N. in Santa Barbara, California. Human
subjects approval was obtained from University of Cali-
fornia, San Francisco (UCSF) Committee on Human
Research and the UCSF Protocol Review Committee
(PRC).
NAF collection
The nipple aspiration technique utilized on this cohort
was developed by Dr. Otto Sartorius [9]. Dr Sartorius per-
formed all NAF attempts on this cohort for the specified
time period. The aspiration device used was double-cham-
bered. The nipples were scrubbed with 2% acetic acid to
remove encrustations, and then dried before attempting
aspiration. The aspiration device was placed over the nip-
ple and negative pressure was applied with a syringe
attached to the central chamber. If the central chamber
was occluded, negative pressure was applied first to the
outer chamber. Once fluid was observed, the aspiration
device was removed and the fluid was collected in capil-
lary tubes. This procedure was repeated until no addi-
tional fluid was expressed. Any visible or measurable
quantity of NAF was considered a positive NAF sample.
Volume varied from < 1 microliter to greater than 50
microliters. Past studies have shown an increase in cyto-
logic adequacy with an increase in NAF volume [9].
Statistical analysis
Statistical Analysis Software (SAS) [10] version 8.02 was
used for all statistical analyses. Distributions of variables
from women for whom NAF was obtained were compared
to women from whom NAF collection was attempted but
not obtained using SAS procedures FREQ or UNIVARIATE
and p-values were determined from chi-square and t-testsBMC Women's Health 2006, 6:15 http://www.biomedcentral.com/1472-6874/6/15
Page 3 of 8
(page number not for citation purposes)
Table 1: Demographic, menstrual, reproductive, and other characteristics of women from the Sartorius Nipple Aspirate Fluid Cohort, 
1970–1990.
Characteristic Variables N (#) % Median Mean SE
Continuous
Age (years) 3043 43 44.5 0.27
Height (inches) 2927 64.5 64.5 0.05
Earliest Weight (lbs.) 2921 130 136.4 0.49
Body Mass Index 2910 22.3 23.4 0.08
Discrete
Marital Status
Married 1833 60.2
Single 530 17.4
Divorced 307 10.1
Widowed 178 5.9
No Data 195 6.4
Age at Menarche (yrs)
< 10 yrs 25 0.8
10 to 12 yrs 945 31.1
13 to 14 yrs 1259 41.4
> 14 yrs 317 10.4
No Data 497 16.3
History of Pregnancy
Yes 2155 70.8
No 887 29.2
Missing 1 0
Breastfed Any Child
Yes 1209 39.7
No, but history of pregnancy 870 28.6
Never pregnant 887 29.2
Missing 76 2.5
Menopausal
Yes 1328 43.6
No 1600 52.6
No Data 115 3.8
Age at Menopause (yrs)
20 to 29 yrs 98 3.2 7.4*
30 to 39 yrs 297 9.8 22.4*
40 to 49 yrs 498 16.4 37.5*
50 to 59 yrs 401 13.2 30.2*
> 59 yrs 6 0.2 0.5*
Premenopausal 1600 52.6
No Data 143 4.7
Menopause Reason
Natural menopause 500 16.4 37.7†
Hysterectomy only 419 13.8 31.6†
Hysterectomy + 1 ovary 79 2.6 5.9†
Hysterectomy + both ovaries 256 8.4 19.3†
Both ovaries removed only 2 0.1 0.2†
Radiation 3 0.1 0.2†
Chemotherapy 2 0.1 0.2†
Hysterectomy, ovary unkn 4 0.1 0.3†
Premenopausal 1600 52.6
No Data 178 5.8BMC Women's Health 2006, 6:15 http://www.biomedcentral.com/1472-6874/6/15
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for discrete and continuous variables, respectively. Logis-
tic regression analysis was used to estimate odds ratios for
obtaining versus not obtaining fluid for variables individ-
ually adjusted for age and in a multivariate model that
included age, marital status, age at menarche, pregnancy
history, estrogen use, tranquilizer use and endocrine
problems using SAS, PROC LOGISTIC.
Results
The women seen at the clinic were between the ages of
15–89 years at the time of breast fluid extraction.
Although ethnicity data were only recorded for 16% of the
cohort, the geographic area is predominantly Caucasian.
Of the ethnicity information known for 16% of this
cohort, 89.1% of those were Caucasian (N = 443). Cohort
demographics are listed in Table 1.
Fluid was obtained from 1314 women (43%) and
attempted but not obtained from 1729 women (57%).
Overall, the mean age for women who yielded breast fluid
was 41.9 years versus 46.5 years for women from whom
aspiration was unsuccessfully attempted (p=<.0001). NAF
production is lower in women under 30, and then rela-
tively constant for the next 25 years, and then declines in
older age women (Figure 1.) Figure 1 highlights the trend
in breast fluid production in women by 5-year age inter-
vals. A decrease in the ability to obtain fluid is evident in
all categories (premenopausal, natural menopause and all
postmenopausal) beginning at approximately age 55.
In both unadjusted and age-adjusted comparisons, fluid
was more likely to be obtained from women who were
married, had a history of any pregnancy, tranquilizer use,
a younger age at menarche, or endocrine problems
(defined as hypothyroidism, hyperthyroidism or diabe-
tes). Fluid was less likely to be obtained from women who
used exogenous estrogen (Table 3). After multivariate
adjustment, women who were married, had a history of
pregnancy, tranquilizer use and endocrine problems
remained significantly more likely to yield breast fluid,
while a younger age at menarche was no longer signifi-
cantly associated. In addition, menopausal women who
took estrogen were less likely to yield fluid than premen-
opausal women. Adding body mass index (BMI) to the
multivariate analysis did not influence significant factors
appreciably, and therefore, was excluded from the final
analysis. A history of breast-feeding was not significant in
any of the analyses.
Discussion
This study builds on the work of Wrensch et al. [8] and
others in illuminating factors associated with an increased
ability to obtain NAF. Wrensch et al.'s work compared
findings from 5 previous studies with the findings from a
cohort of 1428 women. Four factors were consistently
associated with NAF obtainment in the comparison: 1)
age 35–55 years, 2) an earlier age at menarche, 3) non-
Asian compared to Asian ethnicity and 4) history of lacta-
tion. In the present study, younger age was also found to
External Estrogen (among menopausal women only n = 1328)
Yes 838 63.1
No 466 35.1
No Data 24 1.8
Tranquilizer Use
Yes 365 12
No 2510 82.5
No Data 168 5.5
Oral Contraceptive Pills
Yes 1580 51.8
No 1124 36.9
No Data 339 11.1
Endocrine Problems** 508 16.7
Yes 2393 78.6
No 142 4.7
No Data
SE, standard error of the Mean
* Percentage is among 1328 menopausal women with 28 missing age at menopause.
† Percentage from 1328 menopausal women with 63 missing menopause reason.
** Among women with endocrine problems 61 had diabetes, 21 had hyperthyroidism, 382 had hypothyroidism, and other types of endocrine 
problems are unknown.
Table 1: Demographic, menstrual, reproductive, and other characteristics of women from the Sartorius Nipple Aspirate Fluid Cohort, 
1970–1990. (Continued)BMC Women's Health 2006, 6:15 http://www.biomedcentral.com/1472-6874/6/15
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be positively associated with obtaining fluid. This is con-
sistent with findings by Wrensch et al. [8], Petrakis et al.
[11], Petrakis et al. [12] and Wnyder et al. [13]. Wrensch
et al. [8] suggested that a decline in secretory activity of the
breast may explain these findings, rather than the onset of
menopause.
Although being married was positively associated in mul-
tivariate analysis with increased ability to obtain fluid in
the present study, it was examined in only one other com-
parison study [14] and was not found to be significant.
Marital status remained significant in all analyses in the
present study, including adjustment for age and a history
of pregnancy, discounting the speculation that confound-
ing of marriage with parity and breast-feeding might
explain the increased ability to obtain fluid. Given there
are no ready biologic reasons to explain this finding, addi-
tional study of this variable is warranted.
A previous history of pregnancy was highly significant in
the present study in all analyses and this is consistent with
findings from Buehring [15] and Petrakis et al. [12]. Pre-
vious studies [8,12,15], found an increased ability to
obtain breast fluid in women with a history of lactation,
although this study did not.
In the present study, postmenopausal women who used
estrogen were significantly less likely to yield fluid com-
pared with premenopausal women. Menopausal estrogen
use was not found to be significant in any of the previous
comparison studies [12-16] with the exception of Petrakis
et al[12], who found that women after age 60 who used
estrogen were significantly more likely to yield fluid than
women who did not use estrogen over the age of 60. This
is in direct contrast to the present study findings; however,
this study did not differentiate estrogen users by age, only
menopausal status. Given the lack of significant findings
in other similar studies, it appears that exogenous estro-
gen use in post-menopausal women may not be an
important determinant of ability to obtain breast fluid. In
fact, in the present study, the inverse was found. In addi-
tion, the present study found that there were no signifi-
cant differences between women who were post-
menopausal and did not take estrogen and premenopau-
sal women after adjusting for age. It seems likely that
endogenous reproductive and menstrual hormones are
Percent of women yielding fluid by menopausal status and 5-year age groups; Sartorius Nipple Aspirate Cohort, 1970–1990 Figure 1
Percent of women yielding fluid by menopausal status and 5-year age groups; Sartorius Nipple Aspirate Cohort, 1970–1990. * 
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partly responsible for the greater ability to obtain NAF in
younger versus older women or in women with intact ova-
ries versus those with bilateral oophorectomy, given
recent studies showing reduced NAF yield in women
undergoing bilateral salpingo-oophorectomy (BSO),
making rates of NAF production for premenopausal
women undergoing BSO similar to the rates of post-men-
opausal women [17]. However, at a certain age (which
likely varies between women), aspects of senescence other
than declining endogenous hormones also might influ-
ence breast physiology, the production of NAF, and the
ability to obtain it. Greater understanding of these factors
would be necessary to explain why exogenous estrogens
do not appear to increase ability to obtain NAF.
Tranquilizer use was positively associated with an
increased ability to yield breast fluid; however, this factor
was not found to be significant in the only comparison
study that considered this factor [12]. Sartorius [18] sug-
gested that some tranquilizers appear to increase breast
secretions but did not formally study the effects for statis-
tical significance. Looking at the pharmaceutical proper-
ties of tranquilizers will be necessary to further ascertain
the role of this type of medication in increasing breast
fluid production. The tranquilizers used during this
period were probably different from tranquilizers that are
used currently; therefore, these findings may not be appli-
cable to today's women. In addition, tranquilizers may
alter the protein and cellular content of NAF, affecting the
fluid biology and its diagnostic value.
The endocrine disorders studied from the Sartorius cohort
produced conflicting findings, given that the disorders
included are diabetes and both hyper- and hypo-thy-
roidism. Wynder et al. [14] studied similar endocrine dis-
orders but did not find any significant associations with
an increased breast fluid yield.
Factors which were not found to be significantly associ-
ated with breast fluid yield in the present study which are
consistent with lack of significance in other studies
include menopausal status and oral contraceptive use.
Only one study found oral contraceptive use to be signif-
icantly related to an increased ability to obtain breast fluid
[15]. The following significant findings in the present
study; marital status, tranquilizer use and a history of
endocrine disorders, have not been widely examined in
other nipple aspirate fluid studies.
While the Sartorius cohort represents a unique group
from which to examine important factors related to
obtaining NAF, the data do have some limitations. Most
notable is that in contrast to other studies, a structured
questionnaire was not used to obtain information on
potentially relevant factors. Instead, the data were
obtained from medical record abstraction. It is possible
that there may have been some inconsistency over time in
how or whether factors were recorded in the medical
records. Also, the cohort included women with suspected
breast disease; therefore, the ability to generalize the find-
ings may be limited. All available information regarding
the characteristics of the cohort was disclosed in Table 1.
Differences between studies in collection of risk factor
data and characteristics of the women themselves may
explain some of the inconsistencies between studies. In
addition, Dr Sartorius was the sole collector of NAF in this
study. Since 1990, the end point for the Sartorius study
data collection, other NAF collection devices have been
developed and different collection techniques have been
tried. The technique mostly commonly used now includes
applying warm compresses to the breast, gentle massage
and the use of an aspiration cup (FirstCyte aspirator; Cytyc
Corporation, Marlborough, MA) [19]. NAF collection
rates may be influenced by the device used, the technique
used, as well as the person performing the NAF collection.
In a 1990 meta-analysis, differences were noted in maxi-
mum pressure used, duration of pressure and definition
of secretor status [8]. All of these factors impact the per-
centage of successful NAF attempts reported. The quantity
of the fluid present, the characteristics of the duct and nip-
ple and the proficiency of the investigator collecting the
specimen (which appears to increase after > 30 different
Table 2: Comparison of continuous variable mean and medians for women from whom fluid was obtained versus not obtained, 
Sartorius Nipple Aspirate Fluid Cohort, 1970–1990.
NAF Fluid Obtained NAF Fluid NOT Obtained
Continuous Variables N (#) Median Mean SE* N (#) Median Mean SE t-test p-value
Age (years) 1314 41.0 41.9 0.36 1729 45.0 46.5 0.38 <0.0001
Height (inches) 1249 65.0 64.6 0.07 1678 64.5 64.5 0.07 0.87
Earliest Weight (lbs.) 1242 130.0 134.9 0.75 1679 132.0 137.4 0.64 0.002
Body Mass Index 1239 22.1 23.1 0.12 1671 22.4 23.6 0.11 0.001
* SE, standard error of the MeanBMC Women's Health 2006, 6:15 http://www.biomedcentral.com/1472-6874/6/15
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individual NAF collections) also influence the success
rates reported [4]. Regardless of technique used, collection
rates are consistently higher in younger women.
Conclusion
Taken together, this and other studies suggest that age is
the most consistent factor affecting obtainment of breast
fluid. Wrensch et al. [4,8] obtained NAF from 42% of
women less than 50 years of age. This study found NAF
was obtained from roughly half of all women under 50
years, decreasing markedly after age 50 (49% and 26%
respectively). Nipple aspirate fluid analysis may hold
promise for younger women who do not fully benefit
from current breast cancer risk assessment tools and/or
Table 3: Unadjusted, adjusted, and multivariate analyses of factors influencing the ability to obtain nipple aspirate fluid (NAF), 
Sartorius Nipple Aspirate Fluid Cohort, 1970–1990.
No NAF
Obtained
NAF
Obtained
Chi-square Age-adjusted Odds Multivariate* adjusted 
Odds
VARIABLE N (%) N (%) p-value Ratio 95% CI* p-value Ratio 95% CI p-value
Marital Status
No 617 (60.8) 398 (39.2)
Yes 988 (53.9) 845 (46.1) 0.0004 1.39 1.19 1.63 <0.0001 1.30 1.06 1.59 0.01
Age at Menarche
13 and older 981 (62.3) 595 (37.8) 0.004 1.19 1.01 1.41 0.04 1.18 0.98 1.43 0.08
12 or younger 548 (56.5) 422 (43.5)
Pregnancy History
Never pregnant 546 (61.6) 341 (38.4)
Ever pregnant 1183 (54.9) 972 (45.1) 0.0007 1.66 1.40 1.97 <0.0001 1.55 1.24 1.94 0.0001
Breastfed Children
Never Breastfed 483 (55.5) 387 (44.5)
Ever Breastfed 663 (54.8) 546 (45.2) 0.76 0.96 0.80 1.15 0.65
Menopause
No 845 (52.8) 755 (47.2)
Yes 838 (63.1) 490 (36.9) <0.0001 1.04 0.84 1.29 0.73
Estrogen Use
No 1116 (56.1) 755 (47.2)
Yes 580 (63.2) 489 (36.9) 0.02 1.23 1.02 1.48 0.03
Menopausal status and Estrogen use
Premenopausal women 822 (53.3) 721 (46.7 <0.0001 referent referent
Menopausal and NO estrogen 293 (62.9) 173 (37.1) 1.00 0.77 1.29 0.99 0.76 0.55 1.04 0.09
Menopausal and estrogen 538 (64.2) 300 (35.8) 1.01 0.79 1.28 0.94 0.71 0.52 0.95 0.02
Oral Contraceptive Pills
No 715 (63.6) 409 (36.4)
Yes 873 (55.3) 707 (44.8) <0.0001 0.98 0.82 1.17 0.82
Tranquilizer Use
No 1501 (59.8) 1009 (40.2)
Yes 145 (39.7) 220 (60.3) <0.0001 2.50 2.00 3.15 <0.0001 2.20 1.63 2.98 <0.0001
Endocrine Problems
Never 1401 (58.6) 992 (41.5)
Ever had 273 (53.7) 235 (46.3) 0.05 1.47 1.21 1.80 0.0001 1.39 1.07 1.81 0.01
* Multivariate model is adjusted for age, marital status, age at menarche, any pregnancy history, the combination of menopausal status and estrogen 
use, tranquilizer use, and endocrine problems (in the multivariate model N = 2104)
** CI, Confidence interval
Total number of women for whom NAF fluid was not obtained = 1729 (56.8%)
Total number of women for whom NAF fluid was obtained = 1314 (43.2%)
Total number of women, N = 3043BMC Women's Health 2006, 6:15 http://www.biomedcentral.com/1472-6874/6/15
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breast cancer detection methods. More studies evaluating
the feasibility of examining breast cells from NAF, as well
as clarifying the most likely population for its use, are nec-
essary.
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